JPMorgan Chase & Co’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.9M | Buy |
|
|||||
|
2025
Q1 | $11M | Buy |
|
|||||
|
2024
Q4 | $7.31M | Sell |
|
|||||
|
2024
Q3 | $7.2M | Buy |
|
|||||
|
2024
Q2 | $4.21M | Buy |
|
|||||
|
2024
Q1 | $2.57M | Buy |
|
|||||
|
2023
Q4 | $1.69M | Buy |
|
|||||
|
2023
Q3 | $931K | Buy |
|
|||||
|
2023
Q2 | $400K | Sell |
|
|||||
|
2023
Q1 | $512K | Buy |
|
|||||
|
2022
Q4 | $286K | Buy |
|
|||||
|
2022
Q3 | $221K | Sell |
|
|||||
|
2022
Q2 | $301K | Buy |
|
|||||
|
2022
Q1 | $317K | Buy |
|
|||||
|
2021
Q4 | $153K | Buy |
|
|||||
|
2021
Q3 | $124K | Buy |
|